Does Massachusetts GIC (state employee plans) cover Zepbound or Wegovy?
Last updated
Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify.
If it is not covered: the lowest cash prices now
- F
Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$118/mo · $118 a month

Compounded tirzepatide, not FDA-approved: at a seller we link to
$129/mo · about $12 more per 30 days than FlatRx

Compounded semaglutide, not FDA-approved: at a seller we link to
$99/mo · about $22 more per 30 days than Sunlight

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$78/mo · about $84 per 30 days
Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify. The Group Insurance Commission ended coverage of GLP-1s prescribed only for obesity on June 30, 2026 for non-Medicare members, and ends it on December 31, 2026 for Medicare members. In its words: "Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY2026), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members." (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026). Its June notice says weight-loss GLP-1 medicines are not covered from July 1, 2026, that some members may still qualify through a medical condition, and that diabetes medicines are not affected. In its words: "Weight loss GLP-1 medicines will not be covered starting July 1, 2026. Some members may still qualify based on medical conditions. Diabetes medicines are not impacted." (GIC, June Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/june-update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026). From July 1, 2026 these prescriptions need prior authorization through CVS. In its words: "Medications will require prior authorization through CVS" (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026).
Massachusetts GIC (state employee plans), Zepbound and Wegovy: common questions
Does Massachusetts GIC (state employee plans) cover Zepbound for weight loss?
Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify. The Group Insurance Commission ended coverage of GLP-1s prescribed only for obesity on June 30, 2026 for non-Medicare members, and ends it on December 31, 2026 for Medicare members. In its words: "Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY2026), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members." (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026). Its June notice says weight-loss GLP-1 medicines are not covered from July 1, 2026, that some members may still qualify through a medical condition, and that diabetes medicines are not affected. In its words: "Weight loss GLP-1 medicines will not be covered starting July 1, 2026. Some members may still qualify based on medical conditions. Diabetes medicines are not impacted." (GIC, June Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/june-update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026). From July 1, 2026 these prescriptions need prior authorization through CVS. In its words: "Medications will require prior authorization through CVS" (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026). Zepbound not covered: the cash price at your dose
Does Massachusetts GIC (state employee plans) cover Wegovy for weight loss?
Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify. The Group Insurance Commission ended coverage of GLP-1s prescribed only for obesity on June 30, 2026 for non-Medicare members, and ends it on December 31, 2026 for Medicare members. In its words: "Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY2026), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members." (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026). Its June notice says weight-loss GLP-1 medicines are not covered from July 1, 2026, that some members may still qualify through a medical condition, and that diabetes medicines are not affected. In its words: "Weight loss GLP-1 medicines will not be covered starting July 1, 2026. Some members may still qualify based on medical conditions. Diabetes medicines are not impacted." (GIC, June Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/june-update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026). From July 1, 2026 these prescriptions need prior authorization through CVS. In its words: "Medications will require prior authorization through CVS" (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026). Wegovy not covered: the cash price at your dose
Does Massachusetts GIC (state employee plans) cover Zepbound for sleep apnea?
A doctor can still request coverage for moderate to severe obstructive sleep apnea with a current BMI of 30 or more. In its words: "Treatment of moderate to severe obstructive sleep apnea in adults with obesity Requires a current BMI ≥ 30 kg/m²" (GIC, June Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/june-update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026).
Does Massachusetts GIC (state employee plans) cover Wegovy for heart disease?
And to reduce major cardiovascular events in adults with established cardiovascular disease and a baseline BMI of 27 or more. In its words: "Risk Reduction of Major Adverse Cardiovascular Events in adults with established cardiovascular disease and obesity or overweight Requires a baseline BMI ≥ 27 kg/m²" (GIC, June Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/june-update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026).
Is Massachusetts GIC (state employee plans) dropping GLP-1 coverage for weight loss?
Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify. The Group Insurance Commission ended coverage of GLP-1s prescribed only for obesity on June 30, 2026 for non-Medicare members, and ends it on December 31, 2026 for Medicare members. In its words: "Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY2026), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members." (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, read Nov 19, 2026).
What do Zepbound and Wegovy cost if Massachusetts GIC (state employee plans) does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $118/mo at FlatRx ($118 a month) among sellers that serve Massachusetts; compounded semaglutide from $78/mo at Sunlight (about $84 per 30 days) among sellers that serve Massachusetts. Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.